Histologic grade as prognostic indicator for mucoepidermoid carcinoma: A population-level analysis of 2400 patients

被引:97
作者
Chen, Michelle M. [1 ]
Roman, Sanziana A. [2 ]
Sosa, Julie A. [2 ]
Judson, Benjamin L. [1 ]
机构
[1] Yale Univ, Sch Med, Dept Surg, New Haven, CT 06519 USA
[2] Duke Univ, Sch Med, Dept Surg, Durham, NC USA
来源
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK | 2014年 / 36卷 / 02期
关键词
mucoepidermoid carcinoma; salivary gland carcinoma; parotid gland; survival; lymph node metastases; MAJOR SALIVARY-GLANDS; PAROTID CARCINOMA; MANAGEMENT; NECK; SURVIVAL; CLASSIFICATION; DIAGNOSIS; NEOPLASMS; OUTCOMES; CANCER;
D O I
10.1002/hed.23256
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
BackgroundMucoepidermoid carcinoma (MEC) is an uncommon malignancy. To the best of our knowledge, this is the largest study investigating disease-specific survival (DSS) of parotid MEC and the first population-level study of the distribution of nodal metastases. MethodsPatients with MEC of the parotid gland were identified in the Surveillance, Epidemiology, and End Results (SEER) database (1988-2009). ResultsWe identified 2400 patients with MEC: 522 low grade, 1137 intermediate grade, and 741 high grade. Five-year DSS rates for low-grade, intermediate-grade, and high-grade MEC were 98.8%, 97.4%, and 67.0%, respectively (p < .001). Negative prognostic factors included high grade, increasing patient age, and tumor size, extraparenchymal extension, nodal metastases, and distant metastases. High-grade MEC was more likely to have lymph node metastases in levels I to III (34.0%) than low-grade (3.3%) and intermediate-grade MEC (8.1%; p < .001). ConclusionGrade influences the prognosis and distribution of nodal metastases. Results indicate that management guidelines should vary based on grade. (c) 2013 Wiley Periodicals, Inc. Head Neck 36: 158-163, 2014
引用
收藏
页码:158 / 163
页数:6
相关论文
共 28 条
[1]  
ARMSTRONG JG, 1992, CANCER, V69, P615, DOI 10.1002/1097-0142(19920201)69:3<615::AID-CNCR2820690303>3.0.CO
[2]  
2-9
[3]   Management and Outcome of Patients With Mucoepidermoid Carcinoma of Major Salivary Gland Origin: A Single Institution's 30-Year Experience [J].
Aro, Katri ;
Leivo, Ilmo ;
Makitie, Antti A. .
LARYNGOSCOPE, 2008, 118 (02) :258-262
[4]  
AUCLAIR PL, 1992, CANCER, V69, P2021, DOI 10.1002/1097-0142(19920415)69:8<2021::AID-CNCR2820690803>3.0.CO
[5]  
2-7
[6]   HISTOPATHOLOGIC GRADING OF SALIVARY-GLAND NEOPLASMS .1. MUCOEPIDERMOID CARCINOMAS [J].
BATSAKIS, JG ;
LUNA, MA .
ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 1990, 99 (10) :835-838
[7]   Determinants of survival in parotid gland carcinoma: a population-based study [J].
Bhattacharyya, N ;
Fried, MP .
AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2005, 26 (01) :39-44
[8]   Nodal metastasis in major salivary gland cancer - Predictive factors and effects on survival [J].
Bhattacharyya, N ;
Fried, MP .
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2002, 128 (08) :904-908
[9]   Diagnosis and classification of salivary neoplasms: Pathologic challenges and relevance to clinical outcomes [J].
Brandwein, MS ;
Ferlito, A ;
Bradley, PJ ;
Hille, JJ ;
Rinaldo, A .
ACTA OTO-LARYNGOLOGICA, 2002, 122 (07) :758-764
[10]   Mucoepidermoid carcinoma - A clinicopathologic study of 80 patients with special reference to histological grading [J].
Brandwein, MS ;
Ivanov, K ;
Wallace, DI ;
Hille, JJ ;
Wang, B ;
Fahmy, A ;
Bodian, C ;
Urken, ML ;
Gnepp, DR ;
Huvos, A ;
Lumerman, H ;
Mills, SE .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2001, 25 (07) :835-845